Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
13F holders, Q4 2024 (December 31)4holders +2
2new positions
0sold out
$0.99avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Travere Therapeutics Inc. (tvtx 2.25 03/01/29) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were Janus Henderson Group PLC ($4.6M), Jane Street Group, LLC ($1.6M) and Toronto Dominion Bank ($588K).
- Company
- Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
- CUSIP
- 89422GAA5
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $5.1M |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 5,395,000 shares bought and 1,053,257 shares sold, net +4,341,743 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Janus Henderson Group PLC | 0.00% | New | 4,771,000 | $4.6M |
| Jane Street Group, LLC | 0.00% | Reduce -35.1% | 1,708,000 | $1.6M |
| Toronto Dominion Bank | 0.00% | New | 624,000 | $588K |
| Nomura Holdings Inc. | 0.00% | Reduce -87.4% | 18,479 | $322K |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 2.25 03/01/29)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 2.25 03/01/29) the manager owns.